The pilot plant is focused on scaling up beverage production and will support applications
DSM provides Q1 2023 trading update
DSM Acquires Adare Biome for €275 million
DSM completes sale of Engineering Materials business
DSM reports 2022 results
DSM shareholders approve DSM-Firmenich merger at Extraordinary General Meeting
Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.
Royal DSM, a global purpose-led science-based company active in Health, Nutrition and Bioscience, today began construction of a new manufacturing facility at its site in Dalry, Scotland. The plant will significantly increase global production of Bovaer®, DSM’s unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use Bovaer® to reduce global methane emissions and contribute to worldwide methane reduction targets.
CPHI Frankfurt 2022: Innovator Interview – DSM Biomedical
Royal DSM, a global purpose-led science-based company, today announces a halt to Rovimix® Vitamin A production in Sisseln, Switzerland, for at least 2 months commencing January 2, 2023. Rovimix® Vitamin E-50 production will be significantly impacted as well due to its common upstream infrastructure.